Abbvie Inc.Usage: Mavyret treats acute or chronic hepatitis C (genotypes 1–6) in adults and children 3+ without cirrhosis or with compensated cirrhosis. Also indicated for genotype 1 patients previously treated with an NS5A inhibitor or NS3/4A protease inhibitor (but not both).